ZNTL
NASDAQ · Biotechnology
Zentalis Pharmaceuticals Inc
$4.61
+0.57 (+14.11%)
Open$4.01
Previous Close$4.04
Day High$4.88
Day Low$3.96
52W High$6.95
52W Low$1.13
Volume—
Avg Volume954.8K
Market Cap269.80M
P/E Ratio—
EPS$-1.91
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+487.6% upside
Current
$4.61
$4.61
Target
$27.09
$27.09
$17.95
$27.09 avg
$27.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.61M | 27.61M | 25.42M |
| Net Income | -178,578,310 | -2,223,610 | -1,538,415 |
| Profit Margin | -246.0% | -8.1% | -6.1% |
| EBITDA | -204,495,165 | -3,072,165 | -2,609,903 |
| Free Cash Flow | — | -1,433,660 | -1,157,693 |
| Rev Growth | — | +21.3% | +16.0% |
| Debt/Equity | — | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.53 | -1.09% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $361.16 | +0.17% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.13 | -0.16% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $494.74 | -0.98% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $628.06 | -0.59% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $297.43 | +1.33% | 69.3 | 39.97B |